MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
88.8 M |
Market Cap[1] |
$ 28.6 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Agios Pharmaceuticals
AGIO
|
$ 33.25 | 0.78 % | $ 1.93 B | Nasdaq Global Select Market,SPB | USA |
 |
Amarin Corporation plc
AMRN
|
$ 13.0 | 0.08 % | $ 5.39 B | Nasdaq Global Market |  Irlanda |
 |
MeiraGTx Holdings plc
MGTX
|
$ 11.0 | 0.49 % | $ 885 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 4.5 | 4.39 % | $ 14.4 M | Nasdaq Global Select Market | USA |
 |
AbbVie
ABBV
|
$ 261.59 | 0.14 % | $ 463 B | NYSE,SPB | USA |
 |
AbCellera Biologics
ABCL
|
$ 14.59 | 0.4 % | $ 4.36 B | Nasdaq Global Select Market |  Canada |
 |
Abeona Therapeutics
ABEO
|
$ 5.25 | 1.74 % | $ 278 M | Nasdaq Capital Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.78 | 1.92 % | $ 916 M | Nasdaq Global Select Market | Canada |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 20.15 | 0.52 % | $ 3.39 B | Nasdaq Global Select Market,SPB | USA |
 |
Achieve Life Sciences
ACHV
|
$ 8.09 | 5.2 % | $ 353 M | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.62 | 0.77 % | $ 264 M | Nasdaq Global Market |  Schweiz |
 |
Aclaris Therapeutics
ACRS
|
$ 5.26 | 0.85 % | $ 645 M | Nasdaq Global Select Market | USA |
 |
Adagene
ADAG
|
$ 3.2 | 0.28 % | $ 189 M | Nasdaq Global Market |  China |
 |
ADC Therapeutics SA
ADCT
|
$ 1.22 | 0.41 % | $ 155 M | NYSE | Schweiz |
 |
Adial Pharmaceuticals
ADIL
|
$ 4.01 | 0.48 % | $ 2.68 M | Nasdaq Capital Market | USA |
 |
ADMA Biologics
ADMA
|
$ 10.03 | 0.7 % | $ 2.39 B | Nasdaq Global Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 28.9 | 0.45 % | $ 4.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Agenus
AGEN
|
$ 9.93 | 0.4 % | $ 295 M | Nasdaq Capital Market | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.18 | 1.51 % | $ 291 K | NYSE American | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.92 | 3.83 % | $ 237 M | Nasdaq Global Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 9.3 | 3.4 % | $ 626 B | Nasdaq Capital Market |  Britain |
 |
Aldeyra Therapeutics
ALDX
|
$ 1.23 | 13.79 % | $ 73.9 M | Nasdaq Global Select Market | USA |
 |
Alector
ALEC
|
$ 1.85 | 0.27 % | $ 191 M | Nasdaq Global Select Market,SPB | USA |
 |
Aligos Therapeutics
ALGS
|
$ 5.63 | 0.18 % | $ 55.7 M | Nasdaq Global Select Market | USA |
 |
Alkermes plc
ALKS
|
$ 40.52 | 1.62 % | $ 6.67 B | Nasdaq Global Select Market | Irlanda |
 |
Allogene Therapeutics
ALLO
|
$ 1.6 | 0.57 % | $ 353 M | Nasdaq Global Select Market,SPB | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 246.74 | 2.55 % | $ 32.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.86 | 0.34 % | $ 252 M | Nasdaq Global Market | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 1.39 | 2.96 % | $ 74.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 421.51 | 0.07 % | $ 227 B | Nasdaq Global Select Market,SPB | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 25.81 | 0.09 % | $ 1.21 B | Nasdaq Global Select Market | USA |
 |
Amneal Pharmaceuticals
AMRX
|
$ 20.14 | 0.22 % | $ 6.31 B | NYSE | USA |
 |
AnaptysBio
ANAB
|
$ 50.26 | 0.98 % | $ 1.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Anika Therapeutics
ANIK
|
$ 19.66 | 0.1 % | $ 282 M | Nasdaq Global Select Market,SPB | USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 72.65 | 0.04 % | $ 1.46 B | Nasdaq Global Market,SPB | USA |
 |
Annexon
ANNX
|
$ 4.23 | 2.42 % | $ 656 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 1.27 | 1.92 % | $ 26.1 M | NYSE American | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.75 | 0.16 % | $ 4.9 M | Nasdaq Global Select Market,SPB | USA |
 |
Aptevo Therapeutics
APVO
|
$ 1.82 | 0.54 % | $ 574 K | Nasdaq Capital Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 4.63 | 0.11 % | $ 495 M | Nasdaq Global Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 13.69 | 0.36 % | $ 375 M | Nasdaq Global Market,SPB |  Israel |
 |
Ardelyx
ARDX
|
$ 3.42 | 0.88 % | $ 824 M | Nasdaq Global Market | USA |
 |
argenx SE
ARGX
|
$ 958.91 | 1.33 % | $ 58.8 B | Nasdaq Global Select Market |  Niderland |
 |
Armata Pharmaceuticals
ARMP
|
$ 3.67 | 2.23 % | $ 133 M | NYSE American | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 26.43 | 0.09 % | $ 3.36 B | Nasdaq Global Select Market,SPB | USA |
 |
Artelo Biosciences
ARTL
|
$ 4.04 | 1.11 % | $ 764 K | Nasdaq Global Select Market | USA |
 |
Arvinas
ARVN
|
$ 7.74 | 3.13 % | $ 549 M | Nasdaq Global Select Market,SPB | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 65.45 | 1.21 % | $ 8.75 B | Nasdaq Global Select Market,SPB | USA |
 |
Assembly Biosciences
ASMB
|
$ 23.49 | 0.04 % | $ 263 M | Nasdaq Global Select Market,SPB | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 227.83 | 0.5 % | $ 13.8 B | Nasdaq Global Select Market |  Danmark |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.